Latest news
ImmunityBio (IBRX) Tests Its Valuation After UAE ANKTIVA Approval Expands Its Reach - simplywall.stsimplywall.st · Sun, 09 Aug 2026 17:32:03 GMTIBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease - StocktwitsStocktwits · Sat, 08 Aug 2026 18:31:44 GMTWhy ImmunityBio (IBRX) Is Up 6.6% After ANKTIVA’s UAE Expansion and Mixed Q2 Results – And What's Next - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:34:48 GMTThe Bull Case For ImmunityBio (IBRX) Could Change Following ANKTIVA’s Broad UAE Approval And Ongoing Losses - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 06:14:00 GMTIBRX Stock Sees Sharp UAE-Driven Jump Followed By Early August Pullback - TradingViewTradingView · Mon, 03 Aug 2026 23:47:46 GMTWeekly Recap: U.S. papillary-only label expansion and UAE ANKTIVA approval - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTThe Bull Case For ImmunityBio (IBRX) Could Change Following ANKTIVA’s Broad UAE Approval - Learn Why - webull.comwebull.com · Sat, 01 Aug 2026 12:13:46 GMTImmunityBio (IBRX) Could Be 45% Undervalued On UAE ANKTIVA Approval - SahmSahm · Sat, 01 Aug 2026 07:00:00 GMT